Literature DB >> 23880529

Antimicrobial compounds in tears.

Alison M McDermott1.   

Abstract

The tear film coats the cornea and conjunctiva and serves several important functions. It provides lubrication, prevents drying of the ocular surface epithelia, helps provide a smooth surface for refracting light, supplies oxygen and is an important component of the innate defense system of the eye providing protection against a range of potential pathogens. This review describes both classic antimicrobial compounds found in tears such as lysozyme and some more recently identified such as members of the cationic antimicrobial peptide family and surfactant protein-D as well as potential new candidate molecules that may contribute to antimicrobial protection. As is readily evident from the literature review herein, tears, like all mucosal fluids, contain a plethora of molecules with known antimicrobial effects. That all of these are active in vivo is debatable as many are present in low concentrations, may be influenced by other tear components such as the ionic environment, and antimicrobial action may be only one of several activities ascribed to the molecule. However, there are many studies showing synergistic/additive interactions between several of the tear antimicrobials and it is highly likely that cooperativity between molecules is the primary way tears are able to afford significant antimicrobial protection to the ocular surface in vivo. In addition to effects on pathogen growth and survival some tear components prevent epithelial cell invasion and promote the epithelial expression of innate defense molecules. Given the protective role of tears a number of scenarios can be envisaged that may affect the amount and/or activity of tear antimicrobials and hence compromise tear immunity. Two such situations, dry eye disease and contact lens wear, are discussed here.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antimicrobial; contact lens; dry eye; tears

Mesh:

Substances:

Year:  2013        PMID: 23880529      PMCID: PMC3844110          DOI: 10.1016/j.exer.2013.07.014

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  149 in total

1.  C57BL/6 mice lacking Muc1 show no ocular surface phenotype.

Authors:  Y Danjo; L D Hazlett; I K Gipson
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

2.  Assessment of effects of multipurpose contact lens care solutions on human corneal epithelial cells.

Authors:  Kissaou T Tchedre; Masaki Imayasu; Yuichi Hori; H Dwight Cavanagh
Journal:  Eye Contact Lens       Date:  2011-09       Impact factor: 2.018

3.  Contact lens materials, mucin fragmentation and relation to symptoms.

Authors:  Monica Berry; Chris Purslow; Paul J Murphy; Heiko Pult
Journal:  Cornea       Date:  2012-07       Impact factor: 2.651

4.  The concentration of lysozyme and secretory IgA in tears from healthy persons with and without contact lens use.

Authors:  T Vinding; J S Eriksen; N V Nielsen
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-02

5.  Synergic antistaphylococcal properties of lactoferrin and lysozyme.

Authors:  E C Leitch; M D Willcox
Journal:  J Med Microbiol       Date:  1998-09       Impact factor: 2.472

6.  Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa.

Authors:  Minjian Ni; David J Evans; Samuel Hawgood; E Margot Anders; Robert A Sack; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 7.  Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut.

Authors:  N J Mantis; N Rol; B Corthésy
Journal:  Mucosal Immunol       Date:  2011-10-05       Impact factor: 7.313

8.  Human tear fluid protects against Pseudomonas aeruginosa keratitis in a murine experimental model.

Authors:  Mary S F Kwong; David J Evans; Minjian Ni; Brigitte A Cowell; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2007-02-26       Impact factor: 3.441

9.  Secretory phospholipase A2 deposition on contact lenses and its effect on bacterial adhesion.

Authors:  Emma B H Hume; Nerida Cole; Alpesh Parmar; Maxine E Tan; Yulina Aliwarga; Tracey Schubert; Brien A Holden; Mark D P Willcox
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

10.  MicroRNA-762 is upregulated in human corneal epithelial cells in response to tear fluid and Pseudomonas aeruginosa antigens and negatively regulates the expression of host defense genes encoding RNase7 and ST2.

Authors:  James Mun; Connie Tam; Gary Chan; Jong Hun Kim; David Evans; Suzanne Fleiszig
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more
  81 in total

1.  TSP-1 Deficiency Alters Ocular Microbiota: Implications for Sjögren's Syndrome Pathogenesis.

Authors:  Marielle Terzulli; Laura Contreras-Ruiz; Laura Contreras Ruiz; Abirami Kugadas; Sharmila Masli; Mihaela Gadjeva
Journal:  J Ocul Pharmacol Ther       Date:  2015-05-26       Impact factor: 2.671

2.  In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American Ophthalmological Society thesis).

Authors:  Harminder S Dua; Ahmad Muneer Otri; Andrew Hopkinson; Imran Mohammed
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

3.  An Ocular Commensal Protects against Corneal Infection by Driving an Interleukin-17 Response from Mucosal γδ T Cells.

Authors:  Anthony J St Leger; Jigar V Desai; Rebecca A Drummond; Abirami Kugadas; Fatimah Almaghrabi; Phyllis Silver; Kumarkrishna Raychaudhuri; Mihaela Gadjeva; Yoichiro Iwakura; Michail S Lionakis; Rachel R Caspi
Journal:  Immunity       Date:  2017-07-11       Impact factor: 31.745

4.  Comparative portrayal of ocular surface microbe with and without dry eye.

Authors:  ZhenHao Li; Yufang Gong; ShuZe Chen; SiQi Li; Yu Zhang; HuiMin Zhong; ZhouCheng Wang; YiFan Chen; QiXin Deng; YuTing Jiang; LiYing Li; Min Fu; GuoGuo Yi
Journal:  J Microbiol       Date:  2019-08-28       Impact factor: 3.422

Review 5.  Mucosal immune tolerance at the ocular surface in health and disease.

Authors:  Jeremías G Galletti; Mauricio Guzmán; Mirta N Giordano
Journal:  Immunology       Date:  2017-02-20       Impact factor: 7.397

Review 6.  Peptide therapeutics for treating ocular surface infections.

Authors:  Curtis R Brandt
Journal:  J Ocul Pharmacol Ther       Date:  2014-09-24       Impact factor: 2.671

7.  A Commencement for Eye Commensals.

Authors:  Nancy J Reyes; Daniel R Saban
Journal:  Immunity       Date:  2017-07-18       Impact factor: 31.745

Review 8.  Predatory prokaryotes wage war against eye infections.

Authors:  Robert M Q Shanks; Daniel E Kadouri
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 9.  Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.

Authors:  Prit Lakhani; Akash Patil; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2018-11-08       Impact factor: 2.671

Review 10.  Visions of Eye Commensals: The Known and the Unknown About How the Microbiome Affects Eye Disease.

Authors:  Anthony J St Leger; Rachel R Caspi
Journal:  Bioessays       Date:  2018-10-05       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.